Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Egsmose

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Age and Ageing|January 1, 1987
Low serum levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in institutionalized old people: influence of solar exposure and vitamin D supplementationC Egsmose, B Lund, P McNair, et al.
Clinical Rheumatology|August 5, 2004
Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devicesO R Madsen, C Suetta, C Egsmose, et al.
Clinical Physiology (Oxford, England)|July 25, 2000
Effects of silicone breast prostheses on the assessment of body composition by dual-energy X-ray absorptiometryO R Madsen, J S Lorentzen, U B Lauridsen, et al.
Nephron|January 1, 1996
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysisL Brandi, H Daugaard, P K Nielsen, et al.
Clinical Physiology (Oxford, England)|June 11, 1999
Influence of orthopaedic metal and high-density detection on body composition as assessed by dual-energy X-ray absorptiometryO R Madsen, C Egsmose, J S Lorentzen, et al.
Human & Experimental Toxicology|May 1, 1990
Metronidazole elimination is preserved in the elderlyS Loft, C Egsmose, J Sonne, et al.
The Journal of Rheumatology|May 1, 1993
Bone mass and turnover in fibromyalgiaS Jacobsen, A Gam, C Egsmose, et al.
The Journal of Rheumatology|December 1, 1995
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled studyC Egsmose, B Lund, G Borg, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trialK L Faarvang, C Egsmose, P Kryger, et al.
American Journal of Nephrology|January 1, 1992
Long-term suppression of secondary hyperparathyroidism by intravenous 1 alpha-hydroxyvitamin D3 in patients on chronic hemodialysisL Brandi, H Daugaard, E Tvedegaard, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Age and Ageing|January 1, 1987
Low serum levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in institutionalized old people: influence of solar exposure and vitamin D supplementationC Egsmose, B Lund, P McNair, et al.
Clinical Rheumatology|August 5, 2004
Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devicesO R Madsen, C Suetta, C Egsmose, et al.
Clinical Physiology (Oxford, England)|July 25, 2000
Effects of silicone breast prostheses on the assessment of body composition by dual-energy X-ray absorptiometryO R Madsen, J S Lorentzen, U B Lauridsen, et al.
Nephron|January 1, 1996
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysisL Brandi, H Daugaard, P K Nielsen, et al.
Clinical Physiology (Oxford, England)|June 11, 1999
Influence of orthopaedic metal and high-density detection on body composition as assessed by dual-energy X-ray absorptiometryO R Madsen, C Egsmose, J S Lorentzen, et al.
Human & Experimental Toxicology|May 1, 1990
Metronidazole elimination is preserved in the elderlyS Loft, C Egsmose, J Sonne, et al.
The Journal of Rheumatology|May 1, 1993
Bone mass and turnover in fibromyalgiaS Jacobsen, A Gam, C Egsmose, et al.
The Journal of Rheumatology|December 1, 1995
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled studyC Egsmose, B Lund, G Borg, et al.
Annals of the Rheumatic Diseases|October 1, 1993
Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trialK L Faarvang, C Egsmose, P Kryger, et al.
American Journal of Nephrology|January 1, 1992
Long-term suppression of secondary hyperparathyroidism by intravenous 1 alpha-hydroxyvitamin D3 in patients on chronic hemodialysisL Brandi, H Daugaard, E Tvedegaard, et al.
Pageof 4